BUILDING BLOCKS, LIBRARIES AND RESINS: LION BIOSCIENCE AG

Lion Bioscience AG, after aquiring Trega Biosciences Inc., now offers its diverse combinatorial libraries (Chem.folio™) as part of its iDiscovery™ technologies and services for drug discovery.

Lion Bioscience 's Chem.folio™ compiles around 400,000 small-molecule, heterocyclic compounds formatted as single-compound arrays with an average purity of over 80%. These compounds posses drug-like properties using Trega's proprietary iDEA™ computational modules.

For more information on Lion Bioscience 's Chem.folio™ click here.

For a review on Lion Bioscience 's iDiscovery™ technologies and services for drug discovery here at CombiChem Lab click here.

Lion Bioscience 's Chem.folio™ compounds are also distributed through ChemNagivator.com Inc. To read a review on ChemNavigator.com here at CombiChem Lab click here.